Hospital Universitario Infanta Sofía

Futó vizsgálatok

• Toboroz

  Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360

  NCT07323316· Ad scientiam· Forrás

• Toboroz

  A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)

  NCT07465757· 2. fázis· Puma Biotechnology, Inc.· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  2025-523670-17-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

  NCT07478991· 3. fázis· PETHEMA Foundation· Forrás

• Toboroz

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis

  2025-525127-27-00· 1/2. fázis· Aurinia Pharmaceuticals Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

  NCT07486934· 3. fázis· Dyne Therapeutics· Forrás

• Toboroz

  A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s ineligible for standard induction chemotherapy

  2025-522979-29-00· 3. fázis· Fundacion PETHEMA· Forrás

• Toboroz

  AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  NCT07509307· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  NCT07481630· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Forrás

• Toboroz

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  NCT07217587· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

  NCT07372170· Infanta Leonor University Hospital· Forrás

• Fut, nem toboroz

  Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

  NCT07160608· 2. fázis· Alexion Pharmaceuticals, Inc.· Forrás

• Toboroz

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial

  2024-512132-29-00· 2. fázis· Swiss Group for Clinical Cancer Research· Forrás

• Toboroz

  A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  NCT06976268· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Toboroz

  The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapy in Heart Failure (ABDOPOCUS-HF)

  2024-512901-22-00· 3. fázis· Fundacion Instituto De Investigacion Sanitaria Aragon· Forrás

• Toboroz

  Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism

  2024-511959-18-01· 3. fázis· Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal· Forrás

• Fut, nem toboroz

  Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-508235-31-00· 3. fázis· Almirall S.A.· Forrás

• Toboroz

  Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  NCT06133972· 3. fázis· Novartis Pharmaceuticals· Forrás

• Meghívásos bevonás

  Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy

  NCT06138743· 1/2. fázis· Sarepta Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

  NCT05639114· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

  NCT05556096· 3. fázis· Alexion Pharmaceuticals, Inc.· Forrás

• Toboroz

  NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

  NCT05558319· 3. fázis· PETHEMA Foundation· Forrás

• Fut, nem toboroz

  Extended VRD plus Early Rescue vs Isatuximab-VRD vs Isatuximab-VIberdomide-D for NDMM patients who are candidates for ASCT

  2024-517008-12-00· 3. fázis· Fundacion PETHEMA· Forrás

• Toboroz

  Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

  NCT04989647· 3. fázis· The Central and Eastern European Gynecologic Oncology Group· Forrás

• Fut, nem toboroz

  Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

  NCT04877691· 3. fázis· AstraZeneca· Forrás

• Toboroz

  LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  NCT04752722· 1/2. fázis· enGene, Inc.· Forrás

• Fut, nem toboroz

  Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

  NCT04090736· 3. fázis· PETHEMA Foundation· Forrás

• Toboroz

  Thoracic Tumours Register

  NCT02941458· Spanish Lung Cancer Group· Forrás

• Toboroz

  Computerized Registry of Patients With Venous Thromboembolism (RIETE)

  NCT02832245· Manuel Monreal· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Myasthenia gravis5 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Deep vein thrombosis and pulmonary embolism2 toboroz
• Elhízás2 toboroz
• Lupus (SLE)2 toboroz
• Myotonic dystrophy2 toboroz
• Osteoarthritis2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Antiphospholipid syndrome1 toboroz
• Asztma1 toboroz
• Gyermekkori daganatok1 toboroz
• Hólyagrák1 toboroz
• Méhnyakrák1 toboroz
• Mielóma multiplex1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Prosztatarák1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)

  NCT06837090· Grupo Espanol de Tumores Neuroendocrinos· Forrás

• Lezárult

  A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

  NCT05931367· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

  NCT05898841· 4. fázis· Fundacion SEIMC-GESIDA· Forrás

• Lezárult

  Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment regimen in HIV-infected patients with metabolic liver disease who maintain undetectable HIV viral load

  2022-503110-23-00· 4. fázis· Fundacion Seimc Gesida· Forrás

• Lezárult

  A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

  NCT05357989· 3. fázis· Annovis Bio Inc.· Forrás

• Lezárult

  Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of life, when given along with other lipid lowering medications.

  2024-511263-28-00· 4. fázis· Novartis Pharma AG· Forrás

• Lezárult

  CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIMUMAB, OR THEIR COMBINATION IN NON INFECTIOUS NON ANTERIOR UVEITIS: A MULTICENTER, RANDOMIZED, PARALLEL 3 ARMS, ACTIVE-CONTROLLED, PHASE 3 OPEN LABEL WITH BLINDED OUTCOME ASSESSMENT STUDY.

  2024-513123-17-00· 3. fázis· Fundacion Para La Investigacion Biomedica Del Hospital Clinico San Carlos· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

  NCT03602859· 3. fázis· Tesaro, Inc.· Forrás

• Lezárult

  Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

  NCT03555422· 3. fázis· Karyopharm Therapeutics Inc· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Eosinophilic oesophagitis4 munka · 0 vizsgálat